More about

Syncope

News
January 21, 2025
2 min read
Save

Rate of postural orthostatic tachycardia syndrome increased after COVID-19 pandemic

After the COVID-19 pandemic, the incidence rate of postural orthostatic tachycardia syndrome increased significantly, according to new data published in the European Heart Journal – Quality of Care and Clinical Outcomes.

News
November 13, 2023
3 min read
Save

Intensive BP lowering confers mortality benefit in Asian cohort

PHILADELPHIA — An intensive systolic BP target of less than 120 mm Hg for Asian patients with hypertension reduced risk for CV and all-cause mortality over 3 years vs. standard care, a speaker reported.

News
October 02, 2023
1 min read
Save

FDA clears next-generation insertable device for long-term arrhythmia monitoring

Boston Scientific announced the FDA clearance and launch of its next-generation insertable cardiac monitor for long-term monitoring of arrhythmias associated with atrial fibrillation, cryptogenic stroke and syncope.

News
September 06, 2023
2 min read
Save

Atrial pacing minimization did not lower AF incidence in sinus node dysfunction

Adaptive pacing at a 60 bpm base rate did not reduce atrial fibrillation risk in patients with sinus node dysfunction but did reduce the incidence of syncope or presyncope vs. a 40 bpm base rate without adaptive pacing, a speaker reported.

News
November 22, 2022
1 min read
Save

Arrhythmias common in patients with syncope

CHICAGO — Among patients with a history of syncope who had ambulatory ECG monitoring, nearly four of five had an arrhythmia, researchers reported at the American Heart Association Scientific Sessions.

News
December 05, 2021
2 min read
Save

Yoga a promising adjunctive therapy for recurrent vasovagal syncope, study finds

In patients with recurrent vasovagal syncope, yoga as an adjunctive therapy was superior to standard therapy only for reducing symptomatic burden and improving quality of life, researchers reported.

News
April 23, 2021
3 min read
Save

SPRINT: Patients at most risk derive greatest benefit from intensive BP lowering

Patients with the highest baseline risk factors derived the most benefit from an intensive BP-lowering regimen compared with standard care, according to a secondary analysis of the SPRINT trial.

News
June 12, 2020
8 min read
Save

The Take Home: HRS

In May, the Heart Rhythm Society Annual Scientific Sessions were held virtually for the first time. Attendees were able to access sessions via the HRS Learning Portal at heartrhythm365.org.

News
May 21, 2020
3 min read
Save

Tool calculates risk for life-threatening events in long QT syndrome

Researchers have developed an online calculator to assess 5-year risk for life-threatening arrhythmic events in patients with long QT syndrome.

News
March 28, 2020
6 min read
Save

VICTORIA: Vericiguat reduces events in high-risk HF

Vericiguat, a novel oral soluble guanylate cyclase stimulator, reduced the incidence of HF hospitalization or CV death compared with placebo in patients with high-risk HF, according to data from the VICTORIA trial presented at the American College of Cardiology Scientific Session.

View more